Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Marcus S Noel, ASCO GI22: Latest Advances in Pancreatic Cancer Treatment

4 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 8th 2022

touchONCOLOGY were thrilled to speak to Professor Marcus S Noel (Medstar Georgetown University Hospital, Washington, DC, USA) to summarise the latest developments and data from the ASCO Gastrointestinal Cancers Symposium 2022.

Questions

  1.       What is the rationale for the use of L-asparaginase in the treatment of pancreatic cancer? 00:22-01:00
  2.       Could you give us an overview of the TRYbeCA 1 study? 01:00-02:31
  3.       What were the findings of the KRYSTAL-1 study in FRAS-mutated pancreatic ductal adenocarcinoma? 02:31-03:37
  4.       Following the CISPD3 trial, what is your opinion on the future of PD-1 blockade with chemotherapy in the treatment of pancreatic cancer? 03:47-04:32

Speaker Disclosure: Marcus S Noel has no conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Filmed in coverage of the ASCO Gastrointestinal Cancers Symposium 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup